News from alume biosciences A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 15, 2020, 05:00 ET Alume Receives SBIR Phase II Grant from the NIH to Support Clinical Trial of ALM-488 to Highlight Nerves in Patients Undergoing Head & Neck Surgery

Alume Biosciences, Inc. (Alume) announced today that it has been awarded a $2.5M Phase II Small Business Innovation Research (SBIR) grant from the...
US FDA Allows Trial to Proceed for Alume Biosciences' Nerve Imaging Candidate

May 04, 2020, 08:00 ET US FDA Allows Trial to Proceed for Alume Biosciences' Nerve Imaging Candidate

Alume Biosciences, Inc., a biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use, today announced that it...

May 01, 2020, 12:00 ET Alume Biosciences Completes $5.5M Series A Financing

Alume Biosciences, Inc., a privately held biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use, today...